Advanced Medical Isotope (OTCMKTS:RDGL) Posts Earnings Results

Advanced Medical Isotope (OTCMKTS:RDGL) posted its quarterly earnings data on Monday. The company reported ($0.01) earnings per share for the quarter, Zacks reports. The firm had revenue of $0.02 million for the quarter.

Advanced Medical Isotope Stock Up 0.1%

OTCMKTS:RDGL traded up $0.00 during midday trading on Wednesday, hitting $0.09. The company had a trading volume of 368,268 shares, compared to its average volume of 514,744. Advanced Medical Isotope has a 52-week low of $0.04 and a 52-week high of $0.17. The stock’s fifty day moving average price is $0.08 and its 200-day moving average price is $0.08.

About Advanced Medical Isotope

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.